Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of PTK787/ZK222584 with or without dacarbazine in metastatic malignant melanoma
2005-002192-32Phase 2Terminated
- Sponsor
- University Hospital Schleswig-Holstein
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vatalanib in melanoma (2 arms), sponsored by University Hospital Schleswig-Holstein. Primary endpoint: Overall response rate by RECIST. Started Mar 2006; status: terminated.
02
Drugs
vatalanib
03
Conditions
melanoma
Beyond the preview
Go deeper on 2005-002192-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002192-32.